Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Clinical trial NCT04588428 · COMPLETED

Trial details

NCT number: NCT04588428
Sponsor: Inovio Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Start date: 2021-06-21
Primary completion: 2023-01-19
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.